Successful weaning from inhaled nitric oxide using dipyridamole

European Journal of Cardio-thoracic Surgery

Volumn 24, Issue 5, 2003, Pages 837-839

  Saiki, Yoshikatsu ^a   Nitta, Yoshio ^a   Tsuru, Yusuke ^a   Tabayashi, Koichi ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Dipyridamole; Nitric oxide; Pulmonary hypertension

Indexed keywords

DIPYRIDAMOLE; NITRIC OXIDE; PROSTACYCLIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HEART CATHETERIZATION; HEART SEPTUM DEFECT; HEMODYNAMICS; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG ARTERY PRESSURE; LUNG BIOPSY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURGICAL TECHNIQUE; SUTURE; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; DIPYRIDAMOLE; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; HYPERTENSION, PULMONARY; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; POSTOPERATIVE CARE; VASODILATOR AGENTS;

EID: 0142154299     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(03)00472-X     Document Type: Article

References (10)

1. Barst R. Reduction in recalcitrant pulmonary hypertension after operation for atrial septal defect [Invited commentary]. Ann Thorac Surg. 72:2001;906-907.
2. Miller O.I., Tang S.F., Keech A., Celermajer D.S. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet. 346:1995;51-52.
3. Lavoie A., Hall J.B., Olson D.M., Wylam M.E. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am J Respir Crit Care Med. 153:1996;1985-1987.
4. Giad A., Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 333:1995;214-221.
5. Ivy D.D., Kinsella J.P., Ziegler J.W., Abman S.H. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease. J Thorac Cardiovasc Surg. 115:1998;875-882.
6. Al-Alaiyan S., Al-Omran A., Dyer D. The use of phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide. Intensive Care Med. 22:1996;1093-1095.
7. Schermuly R.T., Roehl A., Weissmann N., Ghofrani H.A., Leuchte H., Grimminger F., Seeger W., Walmrath D. Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 281:2001;L1361-L1368.
8. Foubert L., De Wolf D., Mareels K., Van Belleghem Y., Reyntjens K., Mortier E., Van Nooten G. Intravenous dipyridamole enhances the effects of inhaled nitric oxide and prevents rebound pulmonary hypertension in piglets. Pediatr Res. 52:2002;730-736.
9. Fullerton D.A., Jaggers J., Piedalue F., Grover F.L., McIntyre R.C. Jr. Effective control of refractory pulmonary hypertension after cardiac operations. J Thorac Cardiovasc Surg. 113:1997;363-370.
10. Jiang Z.Y., Costachescu T., Derouin M., Blaise G. Treatment of pulmonary hypertension during surgery with nitric oxide and vasodilators. Can J Anaesth. 47:2000;552-555.